Kronos | KB-ENTO-3001

Clinical Trial Grant

Duke Scholars

Principal Investigator Harry Paul Erba Medicine, Hematologic Malignancies and Cellular Therapy

Administered By

Duke Cancer Institute

Awarded By

Kronos Bio, Inc

Start Date

January 14, 2022

End Date

January 31, 2027

Administered By

Duke Cancer Institute

Awarded By

Kronos Bio, Inc

Start Date

January 14, 2022

End Date

January 31, 2027